Chrome Extension
WeChat Mini Program
Use on ChatGLM

EP08.02-158 Final Analyses of ALTER-L018: A Randomized Phase II Trial of Anlotinib Plus Docetaxel Vs Docetaxel As 2Nd-Line Therapy for EGFR-negative NSCLC

Journal of Thoracic Oncology(2022)

Cited 0|Views3
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined